BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11057312)

  • 1. [Prevention and treatment of the side effects of cancer chemotherapy].
    Iki S; Urabe A
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1635-40. PubMed ID: 11057312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of nausea, vomiting and anorexia due to anticancer agents].
    Shimada K; Taguchi S
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):760-4. PubMed ID: 12852341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Palliative therapy in cancer. 5. Side effects by anticancer drugs and their treatments].
    Urushizaki I
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1959-69. PubMed ID: 1697455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics.
    Morrow GR; Roscoe JA; Kirshner JJ; Hynes HE; Rosenbluth RJ
    Support Care Cancer; 1998 May; 6(3):244-7. PubMed ID: 9629877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.
    Antonarakis ES; Hain RD
    Arch Dis Child; 2004 Sep; 89(9):877-80. PubMed ID: 15321871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives.
    Schwartzberg LS
    J Support Oncol; 2007 Feb; 5(2 Suppl 1):5-12. PubMed ID: 17366928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pavlovian conditioning of nausea and vomiting.
    Stockhorst U; Steingrueber HJ; Enck P; Klosterhalfen S
    Auton Neurosci; 2006 Oct; 129(1-2):50-7. PubMed ID: 16949885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of cytotoxics-platinum agents.
    Selvaratnam G; Philips RH; Mohamed AK; Radzi A
    Adverse Drug React Toxicol Rev; 1997 Aug; 16(3):171-97. PubMed ID: 9512763
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy-induced nausea and vomiting: prevention, detection, and treatment--how are we doing?
    Grunberg SM
    J Support Oncol; 2004; 2(1 Suppl 1):1-10, inside back cover; quiz 11. PubMed ID: 16117016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New agents for controlling emesis with cancer chemotherapy.
    Gralla RJ; Clark RA
    J La State Med Soc; 1993 Apr; 145(4):169-73. PubMed ID: 8486990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
    Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticipatory nausea and anticipatory vomiting, food aversion and anticipatory immunomodulation: classical conditioning in cytostatic drug treatment of pediatric chemotherapy patients].
    Stockhorst U; Spennes S; Saleh A
    Praxis (Bern 1994); 1998 Sep; 87(36):1140-7. PubMed ID: 9782742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprepitant--where do we stand in the control of chemotherapy-induced nausea and vomiting?
    Sarcev T; Secen N; Zaric B; Milovancev A
    J BUON; 2008; 13(3):333-9. PubMed ID: 18979546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' experiences of chemotherapy treatment.
    Colbourne L
    Prof Nurse; 1995 Apr; 10(7):439-42. PubMed ID: 7724633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.
    Mahesh R; Perumal RV; Pandi PV
    Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.
    Oo TH; Hesketh PJ
    Nat Clin Pract Oncol; 2005 Apr; 2(4):196-201. PubMed ID: 16264934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current role of chemotherapy protectors in cancer treatment.
    Cáceres W; Báez L; Aponte I; Rodríguez N; Maldonado A
    Bol Asoc Med P R; 1997; 89(10-12):184-8. PubMed ID: 9577052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.